BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14686968)

  • 21. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manifestations of cutaneous T-cell lymphoma.
    Carney DN; Bunn PA
    J Dermatol Surg Oncol; 1980 May; 6(5):369-77. PubMed ID: 6966639
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
    Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
    Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    Ann Dermatol Venereol; 2005 Oct; 132(10 Suppl):7S153-7S155. PubMed ID: 16419538
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cutaneous lymphomas].
    Ingen-Housz-Oro S; Bagot M
    Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
    Beltraminelli H
    Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.
    Wood GS
    Arch Dermatol; 1998 Feb; 134(2):221-3. PubMed ID: 9487215
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycosis fungoides: cutaneous T-cell lymphoma.
    Zaim MT; Grinkemeyer MD
    Am Fam Physician; 1991 May; 43(5):1703-7. PubMed ID: 2021105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of the primary cutaneous lymphomas.
    Prince HM; McCormack C; Ryan G; O'Keefe R; Seymour JF; Baker C
    Australas J Dermatol; 2003 Nov; 44(4):227-40; quiz 241-2. PubMed ID: 14616487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
    Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
    J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
    Vermeer MH; Nicolay JP; Scarisbrick JJ; Zinzani PL
    Br J Dermatol; 2021 Jul; 185(1):19-25. PubMed ID: 33155285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulomatous slack skin: a distinct disorder or a variant of mycosis fungoides?
    Topar G; Zelger B; Schmuth M; Romani N; Thaler J; Sepp N
    Acta Derm Venereol; 2001; 81(1):42-4. PubMed ID: 11411914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
    Vergier B
    Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
    [No Abstract]   [Full Text] [Related]  

  • 37. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma.
    Salant JA; Khan N; Nelson JE; Norton-Westbrook M; Desai AV
    J Palliat Med; 2022 Jun; 25(6):958-963. PubMed ID: 34978848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
    Olsen EA; Whittaker S; Willemze R; Pinter-Brown L; Foss F; Geskin L; Schwartz L; Horwitz S; Guitart J; Zic J; Kim YH; Wood GS; Duvic M; Ai W; Girardi M; Gru A; Guenova E; Hodak E; Hoppe R; Kempf W; Kim E; Lechowicz MJ; Ortiz-Romero P; Papadavid E; Quaglino P; Pittelkow M; Prince HM; Sanches JA; Sugaya M; Vermeer M; Zain J; Knobler R; Stadler R; Bagot M; Scarisbrick J
    Blood; 2022 Aug; 140(5):419-437. PubMed ID: 34758074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.
    Novelli S; García-Muret P; Mozos A; Sierra J; Briones J
    Leuk Lymphoma; 2016 May; 57(5):1060-6. PubMed ID: 27096891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.